Quality of life, adherence and satisfaction of patients with auricular fibrillation treated with dabigatran or vitamin K antagonists

Autor: V, Barrios, C, Escobar, G, Barón Esquivias, J J, Gómez Doblas, E, Recalde Del Vigo, L, Segura Martínez, P, Alvarez Garcia, F, Alonso Valladares, J, Toril Lopez, J M, Chopo Alcubilla
Rok vydání: 2018
Zdroj: Revista clinica espanola. 219(6)
ISSN: 2254-8874
Popis: To analyse the quality of life, adherence and satisfaction of patients with nonvalvular auricular fibrillation (NVAF) treated with dabigatran versus vitamin K antagonists (VKA) in cardiology consultations in Spain.We conducted an observational, comparative, prospective and multicentre study of patients with NVAF treated in cardiology departments, who started treatment with dabigatran or VKA in the month prior to the baseline visit. The follow-up lasted 6 months. We analysed quality of life (using the validated AF-QoL 18 questionnaire [0, minimum; 100, maximum]), adherence (using the Morisky-Green test) and the cardiologist's perception (using a specific questionnaire [0, completely dissatisfied; 10, completely satisfied]).We analysed 1015 patients (mean age, 73.3±9.4 years; 57% men; CHAFor patients with NVAF and high thromboembolic risk treated in cardiology consultations, the adherence, satisfaction and quality of life were higher for the patients treated with dabigatran than for those treated with VKA.
Databáze: OpenAIRE